Identification of novel potential PI3Kα inhibitors for cancer therapy

Author:

Zhang Qingyan123,Sang Feng23,Qian Jieyu23,Lyu ShaoLi4,Wang Wang1,Wang Ying5,Li Qiang23,Du LinFang1

Affiliation:

1. Key Laboratory of Bio-resources and Eco-environment of the Ministry of Education, College of Life Sciences, Sichuan University, Chengdu, China

2. Department of Acquired Immune Deficiency Syndrome Treatment and Research Center, The First Affiliated Hospital of Henan University of Traditional Chinese Medicine, Zhengzhou, China

3. Henan Key Laboratory of Viral Diseases Prevention and Treatment of Traditional Chinese Medicine, Henan University of Chinese Medicine, Zhengzhou, China

4. Department of Ecology and Resource Engineering, Hetao College, Bayannur, Inner Mongolia, PR of China

5. The Department of Anesthesiology, the First Affiliated of Henan University, Kaifeng, China

Funder

National Natural Science Foundation of China

Special Foundation for Key Basic Research and Promotion Project of Henan

Special Foundation for Traditional Chinese Medicine Research Project of Henan

Publisher

Informa UK Limited

Subject

Molecular Biology,General Medicine,Structural Biology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3